198 related articles for article (PubMed ID: 22187642)
1. Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470.
Verdurand M; Nguyen V; Stark D; Zahra D; Gregoire MC; Greguric I; Zavitsanou K
Int J Mol Imaging; 2011; 2011():548123. PubMed ID: 22187642
[TBL] [Abstract][Full Text] [Related]
2. Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.
Thanos PK; Ramalhete RC; Michaelides M; Piyis YK; Wang GJ; Volkow ND
Synapse; 2008 Sep; 62(9):637-42. PubMed ID: 18563836
[TBL] [Abstract][Full Text] [Related]
3. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
[TBL] [Abstract][Full Text] [Related]
4. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.
Casteels C; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1164-73. PubMed ID: 20182714
[TBL] [Abstract][Full Text] [Related]
5. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
[TBL] [Abstract][Full Text] [Related]
8. Whole-body biodistribution of the cannabinoid type 1 receptor ligand [
Buchholz HG; Uebbing K; Maus S; Pektor S; Afahaene N; Weyer-Elberich V; Lutz B; Schreckenberger M; Miederer I
Nucl Med Biol; 2017 Sep; 52():63-69. PubMed ID: 28648984
[TBL] [Abstract][Full Text] [Related]
9. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
Hamill TG; Lin LS; Hagmann W; Liu P; Jewell J; Sanabria S; Eng W; Ryan C; Fong TM; Connolly B; Vanko A; Hargreaves R; Goulet MT; Burns HD
Mol Imaging Biol; 2009; 11(4):246-52. PubMed ID: 19130142
[TBL] [Abstract][Full Text] [Related]
10. In vivo quantification of neurofibrillary tangles with [
Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
[TBL] [Abstract][Full Text] [Related]
11. Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model.
Vandeputte C; Casteels C; Struys T; Koole M; van Veghel D; Evens N; Gerits A; Dresselaers T; Lambrichts I; Himmelreich U; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1796-806. PubMed ID: 22895861
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice.
Kim J; Horti AG; Mathews WB; Pogorelov V; Valentine H; Brasic JR; Holt DP; Ravert HT; Dannals RF; Zhou L; Jedynak B; Kamiya A; Pletnikov MV; Wong DF
Mol Imaging Biol; 2015 Jun; 17(3):355-63. PubMed ID: 25296765
[TBL] [Abstract][Full Text] [Related]
13. Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
Casteels C; Vanbilloen B; Vercammen D; Bosier B; Lambert DM; Bormans G; Van Laere K
Synapse; 2010 Aug; 64(8):617-23. PubMed ID: 20340169
[TBL] [Abstract][Full Text] [Related]
14. Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats.
Rojo ML; Söderström I; Fowler CJ
Brain Res; 2011 Feb; 1373():195-201. PubMed ID: 21145311
[TBL] [Abstract][Full Text] [Related]
15. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.
Gonzalez S; Fernandez-Ruiz J; Sparpaglione V; Parolaro D; Ramos JA
Drug Alcohol Depend; 2002 Mar; 66(1):77-84. PubMed ID: 11850139
[TBL] [Abstract][Full Text] [Related]
16. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
[TBL] [Abstract][Full Text] [Related]
17. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
[TBL] [Abstract][Full Text] [Related]
18. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
Van Laere K; Goffin K; Casteels C; Dupont P; Mortelmans L; de Hoon J; Bormans G
Neuroimage; 2008 Feb; 39(4):1533-41. PubMed ID: 18077184
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.
Casteels C; Koole M; Celen S; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1467-77. PubMed ID: 22699528
[TBL] [Abstract][Full Text] [Related]
20. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
